Taking people in FranceNo phase
Cohort of Patients With Systemic Granulomatosis and Associated Biological Collection
Key facts
- Who runs it
- University Hospital, Bordeaux
- Where
- Bordeaux, FranceSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 4 Dec 2025
- Expected to end
- Dec 2035
- Type of study
- Observational
- Treatments tested
- blood sample
- urine sample
- Record updated
- 3 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients aged 18 or over
- Patients with systemic granulomatosis (diagnosis proven by anatomopathological sampling) at diagnosis
- Persons affiliated to or benefiting from a social security scheme
- Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research)
Who cannot take part
- Patients already receiving specific treatment for systemic granulomatosis
- Patients infected with human immunodeficiency virus (HIV), Hepatitis B virus (HBV) and/or Hepatitis C virus (HCV)
- Persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent
- Pregnant or breast-feeding women
Where in France
- CHU de Bordeaux - service de Médecine Interne et Immunologie CliniqueBordeaux, FranceContact: Emmanuel RIBEIRO, MDTaking people
About the trial
What the trial wants to find out
The GRAMI-BIO study is a prospective single-centre cohort study to recruit 150 patients followed up in the the Bordeaux University Hospital. The total duration of the GRAMI-BIO study is ten years (five years of inclusion with five years of follow-up): Consecutive inclusion of patients meeting the definition of systemic granulomatosis. The main objective of this cohort is to describe to clinical progression of systemic granulomatosis and to collect blood fraction samples (serum bank, plasma bank, urine bank, DNA bank) from subjects participating in the cohort.
The group in the trial
- Granulomatosis
Treatment: blood sample and urine sample
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Cohort of Patients With Systemic Granulomatosis (Sarcoidosis and Other Systemic Granulomatoses) and Associated Biological Collection GRAMI-BIO Study
- Record updated
- 3 February 2026